Oncología Traslacional

Foto de Oncología Traslacional

Foto de Hospital Universitario de Jaén

Hospital Universitario de Jaén

Jaén, España

Publicaciones en colaboración con investigadores/as de Hospital Universitario de Jaén (5)

2023

Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial
Therapeutic Advances in Medical Oncology, Vol. 15

2022

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics
BMC Cancer, Vol. 22, Núm. 1

2021

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
BMC Cancer, Vol. 21, Núm. 1

2016

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
BMC Cancer, Vol. 16, Núm. 1

2014

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 160-166

Proyecto CRIS desarrollado en colaboración con la Fundación Dialnet (Universidad de La Rioja)